SHARIR DAFNA - 20 Jun 2025 Form 4 Insider Report for ORMAT TECHNOLOGIES, INC. (ORA)

Role
Director
Signature
/s/ Jessica Woelfel - as attorney-in-fact
Issuer symbol
ORA
Transactions as of
20 Jun 2025
Net transactions value
-$137,001
Form type
4
Filing time
24 Jun 2025, 16:24:52 UTC
Previous filing
21 May 2025
Next filing
01 Oct 2025

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
SHARIR DAFNA Director C/O ORMAT TECHNOLOGIES, INC., 6884 SIERRA CENTER PARKWAY, RENO /s/ Jessica Woelfel - as attorney-in-fact 24 Jun 2025 0001181711

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ORA Common Stock Options Exercise $93,013 +1,210 +27% $76.87 5,648 20 Jun 2025 Direct F1
transaction ORA Common Stock Disposed to Issuer $92,957 -1,089 -19% $85.36 4,559 20 Jun 2025 Direct F1
transaction ORA Common Stock Sale $10,366 -121 -2.7% $85.67 4,438 20 Jun 2025 Direct F1
transaction ORA Common Stock Options Exercise $88,815 +1,315 +30% $67.54 5,753 20 Jun 2025 Direct F2
transaction ORA Common Stock Disposed to Issuer $88,782 -1,035 -18% $85.78 4,718 20 Jun 2025 Direct F2
transaction ORA Common Stock Sale $24,027 -280 -5.9% $85.81 4,438 20 Jun 2025 Direct F2
transaction ORA Common Stock Sale $102,696 -1,200 -27% $85.58 3,238 20 Jun 2025 Direct F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ORA Stock Appreciation Rights (SARS) Options Exercise $0 -1,210 -100% $0.000000 0 20 Jun 2025 Common Stock 1,210 $76.87 Direct
transaction ORA Stock Appreciation Rights (SARS) Options Exercise $0 -1,315 -100% $0.000000 0 20 Jun 2025 Common Stock 1,315 $67.54 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the exercise of Stock Appreciation Rights (SARS) expiring on November 06, 2025, for which the reporting person exercised all 1,210 shares, disposed of 1,089 shares to the issuer to cover the exercise price of the SARs, and sold the remaining 121 shares acquired upon exercise in the open market on June 20, 2025. Each SAR represents the right to receive shares of ORA common stock with a value equal to the amount by which the market value of the shares in respect of which the SAR is exercised exceeds the grant price set forth in the SAR, multiplied by the number of shares in respect of which the SAR is exercised.
F2 Represents the exercise of SARS expiring on November 04, 2026, for which the reporting person exercised all 1,315 shares, disposed of 1,035 shares to the issuer to cover the exercise price of the SARs, and sold the remaining 280 shares in the open market on June 20, 2025.
F3 Represents shares of common stock sold in the open market on June 20, 2025.